Keywords: norvartis, submits, gleevec, snda, usa, novartis, submitted

Norvartis submits Gleevec sNDA in USA

Article | 19 October 2001

Print This

Novartis has submitted a supplemental New Drug Application to the USFood and Drug Administration for its cancer treatment Gleevec (imatinib ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in